To: | United Therapeutics Corporation (IPDocketing@foley.com) |
Subject: | U.S. TRADEMARK APPLICATION NO. 88345768 - REMUNITY PUMP FOR REMODULIN - 080618-1869 |
Sent: | 6/3/2019 11:51:28 AM |
Sent As: | ECOM128@USPTO.GOV |
Attachments: |
UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO)
OFFICE ACTION (OFFICIAL LETTER) ABOUT APPLICANT’S TRADEMARK APPLICATION
U.S. APPLICATION SERIAL NO. 88345768
MARK: REMUNITY PUMP FOR REMODULIN
|
|
CORRESPONDENT ADDRESS: |
GENERAL TRADEMARK INFORMATION: http://www.gov.uspto.report/trademarks/index.jsp
|
APPLICANT: United Therapeutics Corporation
|
|
CORRESPONDENT’S REFERENCE/DOCKET NO: CORRESPONDENT E-MAIL ADDRESS: |
|
EXAMINER’S AMENDMENT
DATABASE SEARCH: The trademark examining attorney has searched the USPTO’s database of registered and pending marks and has found no conflicting marks that would bar registration under Trademark Act Section 2(d). TMEP §704.02; see 15 U.S.C. §1052(d).
APPLICATION HAS BEEN AMENDED: In accordance with the authorization granted by Norm Rich, attorney of record, on June 3, 2019, the trademark examining attorney has amended the application as indicated below. Please advise the undersigned immediately of any objections. Otherwise, no response is necessary. TMEP §707. Any amendments to the identification of goods and/or services may clarify or limit the goods and/or services, but may not add to or broaden the scope of the goods and/or services. 37 C.F.R. §2.71(a); see TMEP §§1402.06 et seq.
DISCLAIMER
The following disclaimer statement is added to the record:
No claim is made to the exclusive right to use “PUMP” and “(TREPROSTINIL) INJECTION” apart from the mark as shown.
See 15 U.S.C. §1056(a); TMEP §§1213, 1213.08(a)(i).
IDENTIFICATION OF GOODS
MARK DESCRIPTION
The following description of the mark is added to the record:
The mark consists of the words “REMUNITY PUMP” in dark blue to light blue gradient from left to right; below the wording “REMUNITY PUMP” appears the wording “FOR” in dark blue; the wording “REMODULIN” appears in red to the right of “FOR” and below appears the wording “(TREPROSTINIL) INJECTION” in red; to the left of the wording are three overlapping open circles in red, light blue, and dark blue.
See 37 C.F.R. §2.37; TMEP §§808 et seq.
If applicant has questions regarding this Examiner’s Amendment, please telephone or e-mail the assigned trademark examining attorney. All relevant e-mail communications will be placed in the official application record.
/Megan Aurand/
Megan Aurand
Examining Attorney
Law Office 128
(571) 272-1614
megan.aurand@uspto.gov
PERIODICALLY CHECK THE STATUS OF THE APPLICATION: To ensure that applicant does not miss crucial deadlines or official notices, check the status of the application every three to four months using the Trademark Status and Document Retrieval (TSDR) system at http://tsdr.gov.uspto.report/. Please keep a copy of the TSDR status screen. If the status shows no change for more than six months, contact the Trademark Assistance Center by e-mail at TrademarkAssistanceCenter@uspto.gov or call 1-800-786-9199. For more information on checking status, see http://www.gov.uspto.report/trademarks/process/status/.
TO UPDATE CORRESPONDENCE/E-MAIL ADDRESS: Use the Trademark Electronic Application System (TEAS) form at http://www.gov.uspto.report/trademarks/teas/correspondence.jsp.